(19)
(11) EP 1 037 878 A2

(12)

(88) Date of publication A3:
21.10.1999

(43) Date of publication:
27.09.2000 Bulletin 2000/39

(21) Application number: 98959535.0

(22) Date of filing: 20.11.1998
(51) International Patent Classification (IPC)7C07D 215/38, C07D 241/44, C07D 277/72, A61K 31/47, A61K 31/495, A61K 31/425
(86) International application number:
PCT/US9824/833
(87) International publication number:
WO 9926/927 (03.06.1999 Gazette 1999/22)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.11.1997 US 66758 P

(71) Applicant: NPS PHARMACEUTICALS, INC.
Salt Lake CityUtah 84108 (US)

(72) Inventors:
  • VAN WAGENEN, Bradford, C.
    Salt Lake City, UT 84124 (US)
  • MOE, Scott, T.
    Salt Lake City, UT 84121 (US)
  • SMITH, Daryl, L.
    Salt Lake City, UT 84121 (US)
  • SHEEHAN, Susan, M.
    Salt Lake City, UT 84108 (US)
  • SHCHERBAKOVA, Irina
    Salt Lake City, UT 84103 (US)
  • TRAVATO, Richard
    Salt Lake City, UT 84117 (US)
  • WALTON, Ruth
    Ogden, UT 84403 (US)
  • BARMORE, Robert
    Salt Lake City, UT 84102 (US)
  • DELMAR, Eric, G.
    Salt Lake City, UT 84108 (US)
  • STORMANN, Thomas, M.
    Salt Lake City, UT 84105 (US)

(74) Representative: Frohwitter, Bernhard, Dipl.-Ing. 
Patent- und Rechtsanwälte,Possartstrasse 20
81679 München
81679 München (DE)

   


(54) METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES